Disease status in autosomal dominant osteopetrosis type 2 is determined by osteoclastic properties

Journal of Bone and Mineral Research

Volumn 21, Issue 7, 2006, Pages 1089-1097

  Chu, Kang ^a   Snyder, Richard ^a   Econs, Michael J ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b FACE CL 459 ^*  (United States)

Author keywords

Bone resorption; Integrin v 3; Modifier genes; Osteoclasts; Osteopetrosis

Indexed keywords

COLONY STIMULATING FACTOR 1; F ACTIN; OSTEOCLAST DIFFERENTIATION FACTOR; VITRONECTIN RECEPTOR;

ACID SECRETION; ALBERS SCHOENBERG DISEASE; ARTICLE; AUTOSOMAL DOMINANT DISORDER; AUTOSOMAL DOMINANT OSTEOPOROSIS TYPE 2; CELL CULTURE; CELL MOTILITY; CLCN7 GENE; CONTROLLED STUDY; CYTOSKELETON; DISEASE ACTIVITY; DISEASE SEVERITY; GENE; GENE EXPRESSION; GENE MUTATION; HETEROZYGOTE; HUMAN; HUMAN CELL; MONONUCLEAR CELL; NUCLEOTIDE SEQUENCE; OSTEOCLAST; OSTEOLYSIS; OSTEOSCLEROSIS;

ACID PHOSPHATASE; ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; BONE RESORPTION; CARRIER PROTEINS; CELL DIFFERENTIATION; CELLS, CULTURED; CHILD; CHLORIDE CHANNELS; FEMALE; GENES, DOMINANT; HETEROZYGOTE; HUMANS; ISOENZYMES; LEUKOCYTES, MONONUCLEAR; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; OSTEOCLASTS; OSTEOPETROSIS; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B;

EID: 33745507600     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.060409     Document Type: Article

References (15)

1. Johnston CC Jr, Lavy N, Lord T, Vellios F, Merritt AD, Deiss WP Jr 1968 Osteopetrosis. A clinical, genetic, metabolic, and morphologic study of the dominantly inherited, benign form. Medicine (Baltimore) 47:149-167.
2. Waguespack SG, Koller DL, White KE, Fishburn T, Carn G, Buckwalter KA, Johnson M, Kocisko M, Evans WE, Foroud T, Econs MJ 2003 Chloride channel 7 (ClCN7) gene mutations and autosomal dominant osteopetrosis, type II. J Bone Miner Res 18:1513-1518.
3. Cleiren E, Benichou O, Van Hul E, Gram J, Bollerslev J, Singer FR, Beaverson K, Aledo A, Whyte MP, Yoneyama T, deVernejoul MC, Van Hul W 2001 Albers-Schonberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene. Hum Mol Genet 10:2861-2867.
4. Del Fattore A, Peruzzi B, Rucci N, Recchia I, Cappariello A, Longo M, Fortunati D, Ballanti P, Iacobini M, Luciani M, Devito R, Pinto R, Caniglia M, Lanino E, Messina C, Cesaro S, Letizia C, Bianchini G, Fryssira H, Grabowski P, Shaw N, Bishop N, Hughes D, Kapur R, Datta H, Taranta A, Fornari R, Migliaccio S, Teti A. 2005 Clinical, genetic and cellular analysis of forty-nine osteopetrotic patients: Implications for diagnosis and treatment. J Med Genet 43:315-325.
5. Chu K, Koller DL, Snyder R, Fishburn T, Lai D, Waguespack SG, Foroud T, Econs MJ 2005 Analysis of variation in expression of autosomal dominant osteopetrosis type 2: Searching for modifier genes. Bone 37:655-661.
6. Henriksen K, Gram J, Schaller S, Dahl BH, Dziegiel MH, Bollerslev J, Karsdal MA 2004 Characterization of osteoclasts from patients harboring a G215R mutation in ClC-7 causing autosomal dominant osteopetrosis type II. Am J Pathol 164:1537-1545.
7. Helfrich MH, Ralston SH 2003 Bone research protocols. In: Flanagan AM, Massey, HM (eds.) Generating Human Osteoclasts In Vitro From Bone Marrow and Peripheral Blood, 1st ed. Humana Press, Totowa, NJ, USA, pp. 113-128.
8. Waguespack SG, Buckwalter KA, Econs MJ 2003 Clinical characteristics of 94 subjects with autosomal dominant osteopetrosis type II (ADO2) and chloride channel 7 gene mutations. J Bone Miner Res 18:S2;S43.
9. Frattini A, Pangrazio A, Susani L, Sobacchi C, Mirolo M, Abinun M, Andolina M, Flanagan A, Horwitz EM, Mihci E, Notarangelo LD, Ramenghi U, Teti A, Van Hove J, Vujic D, Young T, Albertini A, Orchard PJ, Vezzoni P, Villa A 2003 Chloride channel ClCN7 mutations are responsible for severe recessive, dominant, and intermediate osteopetrosis. J Bone Miner Res 18:1740-1747.
10. Khosla S 2001 Minireview: The OPG/RANKL/RANK system. Endocrinology 142:5050-5055.
11. Neale SD, Smith R, Wass JA, Athanasou NA 2000 Osteoclast differentiation from circulating mononuclear precursors in Paget's disease is hypersensitive to 1,25-dihydroxyvitamin D(3) and RANKL. Bone 27:409-416.
12. Menaa C, Reddy SV, Kurihara N, Maeda H, Anderson D, Cundy T, Cornish J, Singer FR, Bruder JM, Roodman GD 2000 Enhanced RANK ligand expression and responsivity of bone marrow cells in Paget's disease of bone. J Clin Invest 105:1833-1838.
13. Karsdal MA, Henriksen K, Sorensen MG, Gram J, Schaller S, Dziegiel MH, Heegaard AM, Christophersen P, Martin TJ, Christiansen C, Bollerslev J 2005 Acidification of the osteoclastic resorption compartment provides insight into the coupling of bone formation to bone resorption. Am J Pathol 166:467-476.
14. Kornak U, Kasper D, Bosl MR, Kaiser E, Schweizer M, Schulz A, Friedrich W, Delling G, Jentsch TJ 2001 Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man. Cell 104:205-215.
15. Blair HC, Borysenko CW, Villa A, Schlesinger PH, Kalla SE, Yaroslavskiy BB, Garcia-Palacios V, Oakley JI, Orchard PJ 2004 In vitro differentiation of CD14 cells from osteopetrotic subjects: Contrasting phenotypes with TCIRG1, CLCN7, and attachment defects. J Bone Miner Res 19:1329-1338.